|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current Assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $69,000 and $69,000, respectively | |||||||||||||
| Inventory, net of reserve for obsolescence of $121,000 and $135,000, respectively | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total Current Assets | |||||||||||||
| Property and equipment, net | |||||||||||||
| Right-of-use asset, net | |||||||||||||
| Deferred software licensing agreement | |||||||||||||
| Software licensing agreement, net | |||||||||||||
| Deferred offering costs | |||||||||||||
| Deposits | |||||||||||||
| Total Other Assets | |||||||||||||
| Total Assets | |||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIENCY) | |||||||||||||
| Current Liabilities: | |||||||||||||
| Accounts payable and accrued expenses | |||||||||||||
| Customer deposits | |||||||||||||
| Lease liability, current | |||||||||||||
| Deferred software licensing obligation | |||||||||||||
| Software licensing obligation, current | |||||||||||||
| Warrant liability | |||||||||||||
| Total Current Liabilities | |||||||||||||
| Lease obligations – noncurrent | |||||||||||||
| Convertible debt | |||||||||||||
| Nonrelated Party | |||||||||||||
| Related Party | |||||||||||||
| Total convertible debt | |||||||||||||
| Software licensing fee obligation, net of current | |||||||||||||
| Total Liabilities | |||||||||||||
| Stockholders’ Equity (Deficiency): | |||||||||||||
| Common stock, $.01 par value, 45,000,000 shares authorized, 4,670,396 and 4,592,063 shares issued and outstanding, respectively | |||||||||||||
| Treasury Stock, 200,400 shares | |||||||||||||
| Additional paid-in-capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total Stockholders’ (Deficiency) Equity | |||||||||||||
| Total Liabilities and Stockholders’ (Deficiency) Equity | |||||||||||||
Loading...
